Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer

▪ Fulvestrant With Ribociclib versus Physician's choice treatments for the patients who recurred after completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer as first line treatment

Participants needed: 272
Trial details
Phase: Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: Yeon Hee ParkUpdated: Dec 24, 2025
Eligibility criteria

Participants must be at least 19 years of age at the time of signing the informe... [+18]

Patients whose cancer recurs one year or later after completing adjuvant endocri... [+29]

Read more
Status: Recruiting

Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer

Prevention of Sacituzumab Govitecan-related Neutropenia in Patients with metastatic Triple Nagative Breast Cancer who have received at least one, and no more than two, prior standard of care chemotherapy regimens

Participants needed: 40
Trial details
Phase: Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: Yeon Hee ParkUpdated: Aug 28, 2025Locations: 1
Eligibility criteria

Signed Informed Consent Form (ICF) prior to participation in any study-related a... [+23]

Prior treatment with topoisomerase 1 inhibitors as a free form or as other formu... [+18]

Read more